JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.139, no.5, pp.829-835, 2013 (Journal Indexed in SCI)
Article / Article
Title of Journal :
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
The overall prognosis for recurrent malignant glioma (MG) is extremely poor, and treatment options are limited. We evaluated our multicenter retrospective experience for patients with recurrent MG administering bevacizumab and irinotecan in combination therapy.